Pear Therapeutics

220 employees

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Substance Use Disorder

Therapeutics

mHealth

Digital Healthcare

Software

Pharmaceutical

Opiate Dependence

Mobile Healthcare

Neurogaming

Pharmaceuticals

Date founded

2013

Funding rounds raised

Total raised

$125M

from 29 investors over 29 rounds

Pear Therapeutics raised $125M on December 3, 2021

Investors: The Eleven Fund, Pritzker Vlock Family Office, QUAD Investment Management, SoftBank Investment Advisers, Trustbridge Partners, Shanda Group and Temasek

Pear Therapeutics raised $80M on December 8, 2020

Investors: QUAD Investment Management, Shanda Group, Temasek, SoftBank Investment Advisers, EDBI Pte Ltd and JAZZ Venture Partners

Pear Therapeutics raised $50M on July 7, 2020

Investors: Perceptive Advisors

Pear Therapeutics raised $64M on January 4, 2019

Investors: Bridge Builders Collaborative, JAZZ Venture Partners, EDBI Pte Ltd, Trustbridge Partners, Temasek and 5AM Ventures

Pear Therapeutics raised $50M on January 2, 2018

Investors: Bridge Builders Collaborative, dRx data, 5AM Ventures, JAZZ Venture Partners and EDBI Pte Ltd

Pear Therapeutics raised $20M on February 3, 2016

Investors: Bridge Builders Collaborative, 5AM Ventures and JAZZ Venture Partners

Pear Therapeutics raised undisclosed on March 19, 2015

Investors: 5AM Ventures